(Q53373344)

13 May 2018

title

Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. (English)

1 reference

13 May 2018

6

Yung-Jue Bang

1 reference

13 May 2018

Sang-uk Han

1

object named as

Sang-Uk Han

1 reference

13 May 2018

author name string

Heung-Tae Kim

2

1 reference

13 May 2018

Do Hwan Seong

3

1 reference

13 May 2018

Yong-Suk Kim

4

1 reference

13 May 2018

Yoon-Soo Park

5

1 reference

13 May 2018

Han-Kwang Yang

7

1 reference

13 May 2018

Seong-Jin Kim

8

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 February 2004

1 reference

13 May 2018

published in

Oncogene

1 reference

13 May 2018

volume

23

1 reference

13 May 2018

page(s)

1333-1341

1 reference

13 May 2018

issue

7

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207259

exact match

0 references

cites work

c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Role of transforming growth factor-beta signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Smads: transcriptional activators of TGF-beta responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Inactivation of the E-cadherin-mediated cell adhesion system in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

RUNX transcription factors as key targets of TGF-beta superfamily signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Hereditary aspects of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Regulation of differentiation by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

DPC4/SMAD4 gene alterations in human cancer, and their functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

No mutations of the Smad2 gene in human sporadic gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Somatic alterations of the SMAD-2 gene in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

TGF-beta related genes in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Human Smad3 and Smad4 are sequence-specific transcription activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

Smad3 mutant mice develop metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

How tumors become angiogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

7 January 2021

Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

7 January 2021

Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207259

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207259

1 reference

13 May 2018

PubMed ID

14647420

1 reference

13 May 2018